You just read:

Ibrutinib RESONATE(TM) Data Show Significant Improvements in Progression-Free Survival and Overall Survival in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

News provided by

Janssen Inc.

Jun 02, 2014, 08:00 ET